Effectiveness and safety of Yufengningxin for treating coronary heart disease angina: A protocol for a systematic review and meta-analysis

BACKGROUND: More than 11 million people suffer from coronary heart disease (CHD) angina in China, showing high morbidity and mortality rates. Yufengingxin (YFNX) is a commonly used Chinese patent medicine in CHD angina treatment. The purpose of this protocol is to evaluate the effectiveness and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Bai, Jing, Liu, Lanchun, Gao, Jialiang, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769345/
https://www.ncbi.nlm.nih.gov/pubmed/33350791
http://dx.doi.org/10.1097/MD.0000000000023911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769345/
https://www.ncbi.nlm.nih.gov/pubmed/33350791
http://dx.doi.org/10.1097/MD.0000000000023911

Ejemplares similares